J&J, Actelion merger decision published by EU
MLex Summary: The European Commission has published its decision to approve Johnson & Johnson's purchase of Swiss biotech company Actelion. The EU watchdog cleared the transaction in June, after J&J agreed...To view the full article, register now.
Already a subscriber? Click here to view full article